09:12 AM EDT, 10/03/2024 (MT Newswires) -- Health care stocks were steady premarket Thursday with the Health Care Select Sector SPDR Fund ( XLV ) and iShares Biotechnology ETF ( IBB ) recently inactive.

Hims & Hers Health ( HIMS ) shares declined by almost 13% after the US Food and Drug Administration said that a shortage of tirzepatide injection has been resolved. Hims & Hers and other generic drug makers are allowed to sell versions of FDA-approved drugs when they are in shortage.

Avidity Biosciences ( RNA ) shares were up nearly 3% after the company said the US Food and Drug Administration has lifted the partial clinical hold on investigational therapy delpacibart etedesiran.

Abivax ( ABVX ) shares advanced by more than 2% after the company said an interim analysis from its open-label maintenance study showed that patients with ulcerative colitis maintained clinical remission while taking its obefazimod drug at a reduced dose for up to two additional years.